Healthcare / Health Information ServicesOslo
$26.20
-1.00 (-3.68%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-4.4M · quality 47.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
17/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.1B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-20.6%
↓Gross Margin
81.2%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+17.9%
FCF CAGR
—
FCF margin
-8.6%
FCF / Net income
0.34x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $50.8M · net income $-12.7M · FCF $-4.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $50.8M | $50.8M | $45.7M | $36.8M | $31.0M |
| Net Income | $-12.7M | $-12.7M | $-7.7M | $-11.1M | $-14.3M |
| EBITDA | $-965000.00 | $-965000.00 | $4.2M | $-659000.00 | $-5.4M |
| EPS | -0.16 | -0.16 | -0.10 | -0.14 | -0.18 |
| Gross Margin | 81.2% | 81.2% | 85.4% | 86.0% | 84.6% |
| Operating Margin | -24.5% | -24.5% | -16.9% | -30.9% | -47.3% |
| Net Margin | -24.9% | -24.9% | -16.8% | -30.2% | -45.9% |
| Balance Sheet | |||||
| Debt/Equity | — | — | — | — | 0.00 |
| Current Ratio | 1.66 | 1.66 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.4M | $-4.4M | $-3.2M | $-10.9M | $-13.1M |
| Returns | |||||
| ROE | -20.6% | -20.6% | -10.4% | -13.4% | -14.5% |
| Valuation | |||||
| EV/EBITDA | — | — | 800.19 | — | — |
| P/B | 33.54 | 33.54 | 45.85 | 26.55 | 16.26 |
| Growth & Yield | |||||
| Revenue Growth | 11.3% | 11.3% | 24.0% | 18.6% | — |
| EPS Growth | -65.8% | -65.8% | 31.1% | 20.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-30.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.10 → -0.16
Residual
-30.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.